Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COVID-19: FDA Clarifies New Guidance, NCI Role

Executive Summary

An official from the US agency focused on new coronavirus diagnostic guidance, testing for asymptomatic individuals, and a National Cancer Institute validation project in a recent teleconference.

You may also be interested in...

FDA Authorizes First At-Home COVID-19 Saliva Sample Collection Kit

The US agency has authorized the first COVID-19 test to use at-home saliva sample collection. Rutgers Clinical Genomics Laboratory landed the emergency use authorization.

COVID-19 Antibody Tests Being Abused To Falsely Diagnose Coronavirus Cases, FDA Says

A negative COVID-19 antibody or serology test, even when authorized by FDA, is a poor indicator of whether an individual currently has or is completely immune from contracting coronavirus, the agency said on 4 May, issuing an updated guidance to drive the lesson home.

Warning Letters And Close-Outs – September 2023

It was a quiet month for warning letters at the FDA last month, with the agency issuing no new warning letters and closing out only one. 


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts